IDEAS home Printed from https://ideas.repec.org/r/eee/respol/v39y2010i6p810-821.html
   My bibliography  Save this item

Knowledge sources, patent protection, and commercialization of pharmaceutical innovations

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Ugo Finardi, 2013. "The technological paradigm of Nanosciences and Technologies: a study of science-technology time and space relations," Economía: teoría y práctica, Universidad Autónoma Metropolitana, México, vol. 39(2), pages 11-29, Julio-Dic.
  2. Chang, Ching-Wen & Yamanaka, Takayuki & Kano, Shingo, 2019. "An enforced loop-out knowledge flow facilitates industry competition: Learning from the pharmaceutical and genetically modified seed industries," Technovation, Elsevier, vol. 79(C), pages 11-24.
  3. Andrea Bastianin & Paolo Castelnovo & Massimo Florio & Anna Giunta, 2019. "Technological Learning and Innovation Gestation Lags at the Frontier of Science: from CERN Procurement to Patent," Papers 1905.09552, arXiv.org.
  4. Moaniba, Igam M. & Lee, Pei-Chun & Su, Hsin-Ning, 2020. "How does external knowledge sourcing enhance product development? Evidence from drug commercialization," Technology in Society, Elsevier, vol. 63(C).
  5. Darlenis Herrera-Vallejera & Salvador Gorbea-Portal, 2021. "Pharmacology and Pharmacy: research and innovation analysis," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(3), pages 2513-2522, March.
  6. Sternitzke, Christian, 2013. "An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors," Research Policy, Elsevier, vol. 42(2), pages 542-551.
  7. Natália Barbosa & Ana Paula Faria & Vasco Eiriz, 2014. "Industry- and firm-specific factors of innovation novelty," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 23(3), pages 865-902.
  8. Miozzo, Marcela & DiVito, Lori, 2016. "Growing fast or slow?: Understanding the variety of paths and the speed of early growth of entrepreneurial science-based firms," Research Policy, Elsevier, vol. 45(5), pages 964-986.
  9. Wang, Xuefeng & Zhang, Shuo & Liu, Yuqin & Du, Jian & Huang, Heng, 2021. "How pharmaceutical innovation evolves: The path from science to technological development to marketable drugs," Technological Forecasting and Social Change, Elsevier, vol. 167(C).
  10. Roberto Camerani & Daniele Rotolo & Nicola Grassano, 2018. "Do firms publish? A multi-sectoral analysis," JRC Working Papers on Corporate R&D and Innovation 2018-05, Joint Research Centre.
  11. Igor Rosa Dias Jesus & Helder Gomes Costa, 2015. "Interfaces between production engineering and the public affairs: evidences from bibliometric analysis," Scientometrics, Springer;Akadémiai Kiadó, vol. 105(2), pages 1183-1193, November.
  12. Guderian, Carsten C. & Posth, Jan-Alexander & Grob, Linus, 2023. "Investment decisions and passive portfolio construction utilizing patent analytics: A multi-case study on COVID-19 treatment technologies," The Quarterly Review of Economics and Finance, Elsevier, vol. 92(C), pages 66-87.
  13. Ingo Stiller & Arjen Witteloostuijn & Bart Cambré, 2022. "Determinants of radical drug innovation: a systematic literature review," Management Review Quarterly, Springer, vol. 72(4), pages 967-1016, December.
  14. Caviggioli, Federico & De Marco, Antonio & Montobbio, Fabio & Ughetto, Elisa, 2020. "The licensing and selling of inventions by US universities," Technological Forecasting and Social Change, Elsevier, vol. 159(C).
  15. Qingjun Zhao & Jiancheng Guan, 2013. "Love dynamics between science and technology: some evidences in nanoscience and nanotechnology," Scientometrics, Springer;Akadémiai Kiadó, vol. 94(1), pages 113-132, January.
  16. Mammadaliyev, Farid & Gilsing, Victor & Knoben, J., 2024. "How do firms adapt their portfolios of external collaborations to changing internal organizational attributes? The moderating role of firm age," Other publications TiSEM 56c854b7-ed86-4830-843e-c, Tilburg University, School of Economics and Management.
  17. Guijie Zhang & Yuqiang Feng & Guang Yu & Luning Liu & Yanqiqi Hao, 2017. "Analyzing the time delay between scientific research and technology patents based on the citation distribution model," Scientometrics, Springer;Akadémiai Kiadó, vol. 111(3), pages 1287-1306, June.
  18. Jie Wu & Kathryn Rudie Harrigan & Siah Hwee Ang & Zefu Wu, 2019. "The impact of imitation strategy and R&D resources on incremental and radical innovation: evidence from Chinese manufacturing firms," The Journal of Technology Transfer, Springer, vol. 44(1), pages 210-230, February.
  19. Rotolo, Daniele & Camerani, Roberto & Grassano, Nicola & Martin, Ben R., 2022. "Why do firms publish? A systematic literature review and a conceptual framework," Research Policy, Elsevier, vol. 51(10).
  20. Rahul RK Kapoor & Nicolas van Zeebroeck, 2016. "The laws of action and reaction: on determinants of patent disputes in European chemical and drug industries," Working Papers TIMES² WP 2016-019, ULB -- Universite Libre de Bruxelles.
  21. Sampat, Bhaven N. & Shadlen, Kenneth C., 2017. "Secondary pharmaceutical patenting: A global perspective," Research Policy, Elsevier, vol. 46(3), pages 693-707.
  22. Xue Yang & Hao Zhang & Die Hu & Bingde Wu, 2023. "The timing dilemma: understanding the determinants of innovative startups’ patent collateralization for loans," Small Business Economics, Springer, vol. 60(1), pages 371-403, January.
  23. Wang, Fang, 2024. "Does the recombination of distant scientific knowledge generate valuable inventions? An analysis of pharmaceutical patents," Technovation, Elsevier, vol. 130(C).
  24. Yoon, Jeeyoung & Syafiandini, Arida Ferti & Song, Min, 2023. "Exploring the knowledge certainty shift: Metaknowledge analysis on drugs via assertion uncertainty burstiness," Journal of Informetrics, Elsevier, vol. 17(2).
  25. Gianluca Fabiano & Andrea Marcellusi & Giampiero Favato, 2020. "Public–private contribution to biopharmaceutical discoveries: a bibliometric analysis of biomedical research in UK," Scientometrics, Springer;Akadémiai Kiadó, vol. 124(1), pages 153-168, July.
  26. Shang, Qingyan & Poon, Jessie P.H. & Yue, Qingtang, 2012. "The role of regional knowledge spillovers on China's innovation," China Economic Review, Elsevier, vol. 23(4), pages 1164-1175.
  27. Ingo Stiller & Arjen Witteloostuijn & Bart Cambré, 2021. "Do current radical innovation measures actually measure radical drug innovation?," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(2), pages 1049-1078, February.
  28. Dai, Rong & Watal, Jayashree, 2021. "Product patents and access to innovative medicines," Social Science & Medicine, Elsevier, vol. 291(C).
  29. Anna Giunta & Filippo M. Pericoli & Eleonora Pierucci, 2016. "University–Industry collaboration in the biopharmaceuticals: the Italian case," The Journal of Technology Transfer, Springer, vol. 41(4), pages 818-840, August.
  30. Giovanni Cerulli & Giovanni Marin & Eleonora Pierucci & Bianca Potì, 2022. "Do company-owned academic patents influence firm performance? Evidence from the Italian industry," The Journal of Technology Transfer, Springer, vol. 47(1), pages 242-269, February.
  31. Yang, Guancan & Lu, Guoxuan & Xu, Shuo & Chen, Liang & Wen, Yuxin, 2023. "Which type of dynamic indicators should be preferred to predict patent commercial potential?," Technological Forecasting and Social Change, Elsevier, vol. 193(C).
  32. Sommer, Daniel & Bhandari, Krishna Raj, 2022. "Internationalization of R&D and Innovation Performance in the Pharma Industry," Journal of International Management, Elsevier, vol. 28(3).
  33. Amel Attour & Pierre Barbaroux, 2016. "The Role of Knowledge Processes in a Business Ecosystem's Lifecycle," Post-Print hal-03223699, HAL.
  34. Eleonora Pierucci, 2015. "University-industry linkages. Among italian regions: a supply-demand analysis," RIVISTA DI ECONOMIA E STATISTICA DEL TERRITORIO, FrancoAngeli Editore, vol. 2015(2), pages 5-33.
  35. Wagner, Stefan & Wakeman, Simon, 2016. "What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry," Research Policy, Elsevier, vol. 45(5), pages 1091-1102.
  36. Salandra, Rossella, 2018. "Knowledge dissemination in clinical trials: Exploring influences of institutional support and type of innovation on selective reporting," Research Policy, Elsevier, vol. 47(7), pages 1215-1228.
  37. Claudimar Pereira da Veiga & Cassia Rita Pereira da Veiga & Mônica Maier Giacomini & Heitor Takashi Kato & Jansen Maia Del Corso, 2015. "Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market," International Review of Management and Marketing, Econjournals, vol. 5(3), pages 141-153.
  38. Puccetti, Giovanni & Giordano, Vito & Spada, Irene & Chiarello, Filippo & Fantoni, Gualtiero, 2023. "Technology identification from patent texts: A novel named entity recognition method," Technological Forecasting and Social Change, Elsevier, vol. 186(PB).
  39. Zhao, Shengchao & Zeng, Deming & Li, Jian & Feng, Ke & Wang, Yao, 2023. "Quantity or quality: The roles of technology and science convergence on firm innovation performance," Technovation, Elsevier, vol. 126(C).
  40. Amel Attour & Pierre Barbaroux, 2021. "The Role of Knowledge Processes in a Business Ecosystem’s Lifecycle," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 12(1), pages 238-255, March.
  41. Andrea Bastianin & Paolo Castelnovo & Massimo Florio & Anna Giunta, 2022. "Big science and innovation: gestation lag from procurement to patents for CERN suppliers," The Journal of Technology Transfer, Springer, vol. 47(2), pages 531-555, April.
  42. Du, Jian & Li, Peixin & Guo, Qianying & Tang, Xiaoli, 2019. "Measuring the knowledge translation and convergence in pharmaceutical innovation by funding-science-technology-innovation linkages analysis," Journal of Informetrics, Elsevier, vol. 13(1), pages 132-148.
  43. Bonnin Roca, Jaime & O'Sullivan, Eoin, 2022. "The role of regulators in mitigating uncertainty within the Valley of Death," Technovation, Elsevier, vol. 109(C).
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.